CRAIG A TOOMAN Insider Trading $ENZN ENZON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CRAIG A TOOMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CRAIG A TOOMAN. CRAIG A TOOMAN is Exec VP Finance, CFO in ENZON PHARMACEUTICALS, INC. ($ENZN) and Exec. V.P. Finance, CFO in ENZON PHARMACEUTICALS, INC. ($ENZN) and Executive Vice President in ENZON PHARMACEUTICALS, INC. ($ENZN).
CRAIG A TOOMAN in ENZON PHARMACEUTICALS, INC.
Trading Symbol: ENZNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CRAIG A TOOMAN: Exec. V.P. Finance, CFO, Exec VP Finance, CFO, Executive Vice President
Holdings: 160,480 shares
Current Value: $56,168
Latest Transaction: Jun 22 2010
$ENZN Market Capitalization: $15.28M
$ENZN Previous Close: $0.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CRAIG A TOOMAN in ENZON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 8.59 | 140,800 | 1,209,472 | 159,200 | |
Jun 22 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Sell | S | 11.25 | 123,100 | 1,385,220 | 160,480 | 283.6 K to 160.5 K (-43.41 %) |
Jun 22 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 8.59 | 140,800 | 1,209,472 | 283,580 | 142.8 K to 283.6 K (+98.61 %) |
May 14 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
May 14 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Payment of Exercise | F | 10.90 | 2,126 | 23,173 | 142,780 | 144.9 K to 142.8 K (-1.47 %) |
May 14 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 0.00 | 6,000 | 0 | 144,906 | 138.9 K to 144.9 K (+4.32 %) |
Apr 14 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. V.P. Finance, ... | Option Exercise | M | 0.00 | 16,740 | 0 | 22,320 | |
Apr 14 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. V.P. Finance, ... | Payment of Exercise | F | 10.48 | 5,930 | 62,146 | 138,906 | 144.8 K to 138.9 K (-4.09 %) |
Apr 14 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. V.P. Finance, ... | Buy | M | 0.00 | 16,740 | 0 | 144,836 | 128.1 K to 144.8 K (+13.07 %) |
Jan 29 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Grant | A | 0.00 | 13,932 | 0 | 128,096 | 114.2 K to 128.1 K (+12.20 %) |
Jan 20 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Payment of Exercise | F | 10.91 | 9,446 | 103,056 | 114,164 | 123.6 K to 114.2 K (-7.64 %) |
Jan 20 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | J | 0.00 | 8,333 | 0 | 123,610 | 115.3 K to 123.6 K (+7.23 %) |
Jan 20 2010 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | J | 0.00 | 18,333 | 0 | 123,610 | 105.3 K to 123.6 K (+17.41 %) |
Nov 25 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 0.00 | 3,000 | 0 | 4,000 | |
Nov 25 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Payment of Exercise | F | 10.37 | 1,063 | 11,023 | 127,767 | 128.8 K to 127.8 K (-0.83 %) |
Nov 25 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 0.00 | 3,000 | 0 | 128,830 | 125.8 K to 128.8 K (+2.38 %) |
May 14 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 0.00 | 4,500 | 0 | 6,000 | |
May 14 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Payment of Exercise | F | 6.05 | 1,594 | 9,644 | 125,830 | 127.4 K to 125.8 K (-1.25 %) |
May 14 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 0.00 | 4,500 | 0 | 127,424 | 122.9 K to 127.4 K (+3.66 %) |
Apr 07 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 0.00 | 16,740 | 0 | 39,060 | |
Apr 07 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Sell | S | 6.12 | 5,930 | 36,292 | 122,924 | 128.9 K to 122.9 K (-4.60 %) |
Apr 07 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 0.00 | 16,740 | 0 | 128,854 | 112.1 K to 128.9 K (+14.93 %) |
Jan 21 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Sell | S | 6.33 | 10,306 | 65,237 | 108,806 | 119.1 K to 108.8 K (-8.65 %) |
Jan 21 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | J | 0.00 | 18,334 | 0 | 119,112 | 100.8 K to 119.1 K (+18.19 %) |
Jan 21 2009 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | J | 0.00 | 8,333 | 0 | 119,112 | 110.8 K to 119.1 K (+7.52 %) |
Nov 25 2008 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | M | 0.00 | 3,000 | 0 | 7,000 | |
Nov 25 2008 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | M | 0.00 | 3,000 | 0 | 119,122 | 116.1 K to 119.1 K (+2.58 %) |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Option Exercise | A | 6.95 | 50,000 | 347,500 | 50,000 | |
Jan 07 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Option Exercise | A | 13.08 | 125,000 | 1,635,000 | 125,000 | |
Jan 07 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Page: 1